Hemofília: vizsgálatok itt: Egyesült Államok
43 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEfficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
- Where
- Ann Arbor, Houston, Pittsburgh, San Diego
- Életkor
- 18 év and over
- People
- 35 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06003387 · EU 2023-509590-23-00 - No phaseTaking peoplePharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Where
- Albuquerque, Aurora, Austin, Baltimore, Boston, Chapel Hill, Charleston, Chicago, Cincinnati, Columbia, Dallas, Durham, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, Lebanon, Lexington, Little Rock, Los Angeles, Louisville, Madison, Milwaukee, Minneapolis, Morgantown, Nashville, New Orleans, Oklahoma City, Omaha, Palo Alto, Phoenix, Portland, Providence, Salt Lake City, Seattle, Sioux Falls, Wilmington
- Életkor
- 0 év to 20 év
- People
- 5000 worldwide
- Run by
- Duke University
See details and how to joinNCT04278404 - No phaseTaking peopleATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Where
- Akron, Albuquerque, Atlanta, Austin, Baltimore, Boston, Buffalo, Chapel Hill, Charlotte, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Dayton, Detroit, Gainesville, Green Bay, Greenville, Hartford, Houston, Hyde Park, Indianapolis, Iowa City, Kansas City, Las Vegas, Little Rock, Los Angeles, Memphis, Miami, Milwaukee, Nashville, Newark, New Haven, New Orleans, New York, Norfolk, Oakland, Orlando, Peoria, Philadelphia, Phoenix, Pittsburgh, Providence, Reno, Rochester, Sacramento, San Antonio, San Bernardino, San Diego, San Francisco, Savannah, Scarborough, Seattle, St Louis, St. Petersburg, Tampa, The Bronx, Toledo, Washington D.C., Wilmington, Winston-Salem
- People
- 3000
- Run by
- American Thrombosis and Hemostasis Network
See details and how to joinNCT04398628 - 4. fázisNot yet taking people in Egyesült ÁllamokUnderstanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction
- Where
- Milwaukee
- Életkor
- 0 év to 17 év
- People
- 15
- Run by
- Versiti Blood Health
See details and how to joinNCT07158606 - No phaseNot yet taking people in Egyesült ÁllamokStudy of a Smart Sharps Disposal Device in Patients With Hemophilia
- Where
- Philadelphia
- Életkor
- 18 év and over
- People
- 23
- Run by
- University of Pennsylvania
See details and how to joinNCT07421154 - No phaseTaking peoplePrevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Where
- Boston, Chicago, Cincinnati, Detroit, Indianapolis, Little Rock, Oklahoma City, Palo Alto, San Diego, St. Petersburg
- Életkor
- 6 év to 19 év
- People
- 72
- Run by
- Wayne State University
See details and how to joinNCT05022459 - 1. fázisTaking peopleA Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Where
- Ann Arbor, Chicago, Glendale, Greenville, Hershey, Los Angeles, Metairie, Philadelphia, St Louis
- Életkor
- 18 év to 60 év
- People
- 31 worldwide
- Run by
- Equilibra Bioscience LLC
See details and how to joinNCT06349473 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Las Vegas, Miami, New Orleans, San Antonio, St Louis
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - No phaseTaking peopleATHNdataset Registry
- Where
- Hickory
- People
- 200 000
- Run by
- American Thrombosis and Hemostasis Network
See details and how to joinNCT06820515 - 1. fázisTaking peopleEmicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- Where
- Ann Arbor, Coral Gables, Hershey, Indianapolis, Kansas City, Madison, Mount Pleasant, Orange, Peoria, Redwood City, Seattle, Tampa
- Életkor
- 0 év to 90 év
- People
- 40
- Run by
- Bleeding and Clotting Disorders Institute Peoria, Illinois
See details and how to joinNCT05500807 - No phaseTaking peopleAn Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Rochester
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938 - No phaseTaking peopleHemophilia A Research Program
- Where
- Seattle
- People
- 500
- Run by
- University of Washington
See details and how to joinNCT07414511 - No phaseCsak meghívásosPalliative Care Needs of Children With Rare Diseases and Their Families
- Where
- Washington D.C.
- Életkor
- 12 hónap to 99 év
- People
- 480
- Run by
- Children's National Research Institute
See details and how to joinNCT06938542 - 4. fázisTaking peopleSEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Where
- Atlanta, Boston, Cleveland, Detroit, Greenville, Houston, Kansas City, Lansing, Little Rock, Los Angeles, Minneapolis, Nashville, New Hyde Park, Oklahoma City, Orlando, Phoenix, Rochester, Sacramento, Savannah, Washington D.C.
- Életkor
- 12 év to 100 év
- People
- 55
- Run by
- American Thrombosis and Hemostasis Network
See details and how to joinNCT04647227 - 4. fázisCsak meghívásosA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Ann Arbor, Aurora, Columbus, Detroit, Los Angeles, Louisville, Pittsburgh, Sacramento, San Diego, San Francisco, Shandon, St Louis, Tampa
- Életkor
- 18 év and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00 - 2/3. fázisCsak meghívásosLong-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
- Where
- Ann Arbor, Aurora, Chapel Hill, Houston, Little Rock, Los Angeles, Nashville, Phoenix, Portland, Sacramento, Salt Lake City, San Diego, Seattle, Tampa
- Életkor
- 18 év and over
- People
- 56 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05962398 · EU 2023-503765-37-00 - 4. fázisTaking peopleHemlibra in Mild Hemophilia A
- Where
- Indianapolis
- Életkor
- 5 év to 45 év
- People
- 20
- Run by
- Indiana Hemophilia &Thrombosis Center, Inc.
See details and how to joinNCT04567511 - 1/2. fázisTaking peopleASC618 Gene Therapy in Hemophilia A Patients
- Where
- Little Rock
- Életkor
- 18 év and over
- People
- 12
- Run by
- ASC Therapeutics
See details and how to joinNCT04676048